Abstract:
PURPOSE: A hybrid of amlodipine with layered silicate and a preparation process thereof are provided, which hybrid is easily dispersed in aqueous solution to increase bioavailability of amlodipine, and is non-hygroscopic enabling easy manufacturing of formulation. CONSTITUTION: The hybrid of amlodipine with layered silicate is provided, wherein the amlodipine is inserted between layers of silicate; the layered silicate is selected from montmorillonite, beidellite, nontronite, hectorite, saponite, illite, celadonite, gluconite, clay and bentonite; inorganic salt or organic base is added into the hybride in order to regulate release of amlodipine; the organic base is aminoalkyl metacrylate copolymer or polyvinylacetal diethylaminoacetate; and the inorganic salt is selected from calcium salt, sodium salt, potassium salt and ammonium salt. The process for preparing the hybrid of amlodipine with layered silicate comprises the steps of: (1) dispersing the layered silicate in aqueous solution; (2) dissolving amlodipine in ethanol or water; and (3) mixing the layered silicate solution with the amlodipine solution and stirring them.
Abstract:
PURPOSE: A hybrid for oral administration without bitter taste of macrolide antibiotics is provided to enough release roxithromycin by inserting macrolide antibiotics into inorganic carrier. CONSTITUTION: A method for manufacturing a hybrid for oral administration without bitter taste of macrolide antibiotics comprises: a step of dissolving aqueous dispersion liquid and macrolide antibiotics in water insoluble organic solvent to obtain hybrid of macrolide antibiotics-silicate; and a step of washing and drying the hybrid with water insoluble organic solvent. The drying is performed by spray drying.